196 related articles for article (PubMed ID: 33207685)
21. Survival and Causes of Death among Patients with Intrahepatic Cholangiocarcinoma in the United States from 2000 to 2018.
Elgenidy A; Afifi AM; Jalal PK
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2169-2176. PubMed ID: 36099432
[TBL] [Abstract][Full Text] [Related]
22. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
[TBL] [Abstract][Full Text] [Related]
23. Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma.
Sriwanitchrak P; Viyanant V; Chaijaroenkul W; Srivatanakul P; Gram HR; Eursiddhichai V; Na-Bangchang K
Asian Pac J Cancer Prev; 2011; 12(6):1503-10. PubMed ID: 22126489
[TBL] [Abstract][Full Text] [Related]
24. CA-S27: a novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma.
Silsirivanit A; Araki N; Wongkham C; Vaeteewoottacharn K; Pairojkul C; Kuwahara K; Narimatsu Y; Sawaki H; Narimatsu H; Okada S; Sakaguchi N; Wongkham S
Cancer Sci; 2013 Oct; 104(10):1278-84. PubMed ID: 23809433
[TBL] [Abstract][Full Text] [Related]
25. State of serum markers for detection of cholangiocarcinoma.
Wongkham S; Silsirivanit A
Asian Pac J Cancer Prev; 2012; 13 Suppl():17-27. PubMed ID: 23480761
[TBL] [Abstract][Full Text] [Related]
26. High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo.
Watanabe M; Chigusa M; Takahashi H; Nakamura J; Tanaka H; Ohno T
In Vitro Cell Dev Biol Anim; 2000 Feb; 36(2):104-9. PubMed ID: 10718366
[TBL] [Abstract][Full Text] [Related]
27. Intrahepatic Cholangiocarcinoma in the Liver Explant After Liver Transplantation: Histological Differentiation and Prognosis.
Takahashi K; Obeid J; Burmeister CS; Bruno DA; Kazimi MM; Yoshida A; Abouljoud MS; Schnickel GT
Ann Transplant; 2016 Apr; 21():208-15. PubMed ID: 27068242
[TBL] [Abstract][Full Text] [Related]
28. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
[TBL] [Abstract][Full Text] [Related]
29. Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients.
Janan M; Proungvitaya S; Limpaiboon T; Proungvitaya T; Roytrakul S; Wongkham C; Jearanaikoon P; Chur-in S; Wongkham S
Asian Pac J Cancer Prev; 2012; 13 Suppl():107-14. PubMed ID: 23480771
[TBL] [Abstract][Full Text] [Related]
30. Potential diagnostic and prognostic biomarkers for cholangiocarcinoma in serum and bile.
Wang B; Chen L; Chang HT
Biomark Med; 2016 Jun; 10(6):613-9. PubMed ID: 27232281
[TBL] [Abstract][Full Text] [Related]
31. The association of carbohydrate antigen 19-9 response with radiologic response and survival in intrahepatic cholangiocarcinoma: A prospective cohort study.
Cai QY; Yang P; Yang XL; Zhang XH; Guo LP; Lu XY; Huo L; Ma HB; Wang XD; Zhou HB; Wu L; Jia NY
Cancer; 2023 Oct; 129(19):2999-3009. PubMed ID: 37449788
[TBL] [Abstract][Full Text] [Related]
32. Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinoma.
Angenard G; Merdrignac A; Louis C; Edeline J; Coulouarn C
Dig Liver Dis; 2019 Sep; 51(9):1337-1343. PubMed ID: 31040073
[TBL] [Abstract][Full Text] [Related]
33. Role of immunophenotypic characterisation in prognostic subtyping of intrahepatic cholangiocarcinoma.
Li Z; Huang N; Du Q; Huang W; Wang B; Wang B; Shen G; Zhang H; Shi S; Wang L
Pathology; 2023 Dec; 55(7):979-988. PubMed ID: 37858435
[TBL] [Abstract][Full Text] [Related]
34. Utility of DNA flow cytometry in distinguishing between malignant and benign intrahepatic biliary lesions.
Wen KW; Rabinovitch PS; Wang D; Mattis AN; Ferrell LD; Choi WT
Virchows Arch; 2020 Oct; 477(4):527-534. PubMed ID: 32296928
[TBL] [Abstract][Full Text] [Related]
35. C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis.
Yeh YC; Lei HJ; Chen MH; Ho HL; Chiu LY; Li CP; Wang YC
Am J Surg Pathol; 2017 Dec; 41(12):1630-1641. PubMed ID: 28945626
[TBL] [Abstract][Full Text] [Related]
36. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
[TBL] [Abstract][Full Text] [Related]
37. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
[TBL] [Abstract][Full Text] [Related]
38. Subcentimetric Incidental Intrahepatic Cholangiocarcinoma in an Explant Liver: Diagnostic Difficulty of a Rare Entity.
Mitra S; Geethanjali G; Rathi S; Behera A; Das A
Int J Surg Pathol; 2018 Dec; 26(8):739-744. PubMed ID: 29742944
[TBL] [Abstract][Full Text] [Related]
39. Serum and bile biomarkers for cholangiocarcinoma.
Alvaro D
Curr Opin Gastroenterol; 2009 May; 25(3):279-84. PubMed ID: 19396965
[TBL] [Abstract][Full Text] [Related]
40. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
